
Paul Mouncey
@paulmouncey
Researcher in critical care. Co-Director @icnarc. Views are my own.
ID: 1072131345495875585
10-12-2018 14:10:06
677 Tweet
558 Followers
374 Following


Designing an adaptive platform trial with parents, young people and PICU staff in a National Institute for Health and Care Research accelerator grant. Hereโs how we did it and what the platform should look like: bmjopen.bmj.com/content/15/1/eโฆ ICNARC Dr Tracy Mitchell Dr Beth Deja Julie Menzies Prof Dr Lyvonne Tume RN

Loved working with young people, parents & professionals about how best to design & conduct a PICU platform trial. See our paper here: bmjopen.bmj.com/content/15/1/eโฆ Professor Kerry Woolfall Julie Menzies Doug Gould Paul Mouncey Prof P Ramnarayan (Ram) Dr Beth Deja Sammy Ainsworth

The second trial result for #CCR25 in Titanic Belfast in June is GASTROSAM Gastroenteritis Rehydration of African Children with Severe Acute Malnutrition Register at criticalcarereviews.com/meetings/ccr25


Amazing our 23rd PICU site now open and 3341 patients recruited!!! We are at 70% of our recruitment target .. Fantastic work to all our sites ICNARC Prof Dr Lyvonne Tume RN National Institute for Health and Care Research Julie Menzies Paediatric Critical Care Society




๐ฉ 12 major critical care trials will present their results at #CCR25 ๐ฉ โก๏ธ Join us in person or virtually to hear & discuss the latest evidence in our unique extended presentation format ๐ด Programme -> criticalcarereviews.com/meetings/ccr25โฆ ๐ด Register -> criticalcarereviews.com/meetings/ccr25


๐จUK-ROX TRIAL Results at #CCR25๐จ ๐ ~100 ๐ฌ๐ง ICUs ๐ฅ ~16,500 pts ๐ฏ Conservative vs usual oxygen therapy in invasively ventilated adults ๐ฉบ Outcome: Mortality day 90 ๐ค Will less oxygen save lives? ๐บ Free livestream โ but it's better in person! ๐ criticalcarereviews.com/ccr25



Our thought and analysis in the work of the UK-ROX team๐ UK-ROX Trial Critical Care Reviews #FOAMed #POCUS #FOAMcc #Meded #MedX Presented at the tremendous #CCR25 meeting


Conservative oxygen therapy with a target SpO2 of 90% did not reduce 90-day all-cause mortality compared to usual oxygen therapy in mechanically ventilated adult patients. #CCR25 Critical Care Reviews ja.ma/4mZgVl6


Editorial: The UK-ROX trial demonstrates that targeting lower oxygen saturation in critically ill patients is safe but does not improve outcomes. #CCR25 Critical Care Reviews ja.ma/3FxWhYu


โญ๏ธ We're here at the Intensive Care Society ๐ #SOA25 - you can find us at stand 48 in the Exhibition Hall!


The day just keeps getting better and better, folks! Sunshine and FIVE (yes, you read that right โ FIVE!) randomisations!๐Big thanks to the fabulous teams at Cwm Taf Morgannwg Critical Care and Mid and South Essex NHS Foundation Trust!๐ฅณ Today is officially a record-breaking day!๐ July? More like Ju-can't stop the momentum!๐ช


This morning we also heard from Professor Dan Martin on the latest evidence and rationale for oxygen targets, with particular focus on the implications of the UK-ROX Trial #SOA25


